In this interview with GI Oncology Now, Dr. Ng shares her inspiring journey into oncology, reflecting on the personal and professional experiences that ignited her passion for research and patient care. She delves into her groundbreaking work on the microbiome and vitamin D in colorectal cancer, her role in the establishment of the Young-Onset Colorectal Cancer Center, and the collaborative efforts required to translate scientific discoveries into clinical applications.
GI Oncology Now
The leading medical news resource for practicing oncologists and health care providers treating gastrointestinal malignancies
Advertisement
Latest News
A recent study compared first-line chemotherapy, as the standard of care for PDAC, with other treatment options.
A recent systematic review evaluated the relationship between NLR and the prognosis of patients who receive NAC.
Entinostat has been utilized in other solid tumors for its ability to induce the inhibition of cell proliferation.
Studies of asymptomatic and symptomatic patients have demonstrated lower ctDNA detection in asymptomatic patients.
In several different types of cancer, tumor budding is linked to poor survival outcomes.
The phase III study found that regorafenib improved overall survival in patients with refractory advanced gastric cancer.
Study participants were administered nadunolimab with a standard dose of gemcitabine and nab-paclitaxel (GN) every two weeks.
The SOX chemotherapy regimen for gastric cancer consists of S-1, an oral fluoropyrimidine, in combination with oxaliplatin.
Repeated use of TACE can impair liver function and stimulate tumor angiogenesis.
Dr. Richard Finn provides an overview of the key studies in liver cancer from ESMO 2024.
Advertisement
Roundtable Discussions
Oncology Brothers Event Coverage
GI Oncology Now has exclusive coverage of Advancement in Oncology: Today’s Data for Tomorrow’s Practice, the first event co-hosted by The Oncology Brothers and Mashup Media. Review the breakthrough data on gastrointestinal cancers presented at the event and insights from esteemed experts that bridge the gap between research and practice for community oncologists.
Conference Coverage
The latest news and research updates in GI cancer treatment from the ESMO Congress 2024
The latest news and research updates in GI cancer treatment from the ASCO 2024 Annual Meeting
GI Oncology Now reviews education from ASCO GI 2024, featuring the latest advances in the field of GI cancer research.
GI Oncology Now reviews education from ISGIO 2023, featuring the latest advances in the field of GI cancer research.
Expert Interviews
Advertisement
Advertisement
Editorial Advisory Board
Christopher Lieu, MDEditor | Co-Director of Gastrointestinal Medical Oncology at University of Colorado Medicine
Benjamin Weinberg, MD, FACPEditor | Associate Professor of Medicine at Lombardi Comprehensive Cancer Center
Zev Wainberg, MD, MScEditor | Co-Director of Gastrointestinal Oncology at the University of California, Los Angeles
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.